Pharmacists in Jerome, Idaho


13 Pharmacists found in Jerome
male pharmacist

Dr. Adam James Hill, PHARM D


Pharmacist
218 W Nez Perce, Jerome, ID 83338
208-650-7946     208-324-3323

male pharmacist

Charles Barnes, PHARMD


Pharmacist
2680 S Lincoln Ave, Jerome, ID 83338
208-324-4333    

male pharmacist

Dr. David Nicholas Barker, PHARMD


Pharmacist
523 Nicholas Rd, Jerome, ID 83338
208-670-0093    



male pharmacist

Devon Hope


Pharmacist
111 Pioneer Ct Ste 2, Jerome, ID 83338
208-324-2440     208-324-2165

male pharmacist

Dr. Gary Radford, PHARMD


Pharmacist
1016 S Lincoln Ave, Jerome, ID 83338
208-324-2411     208-324-6531

male pharmacist

Gregory Nelsen


Pharmacist
253 E 650 N, Jerome, ID 83338
623-687-1562    

male pharmacist

Jacob Mccall Schimpf, PHARMD


Pharmacist
2680 S Lincoln Ave, Jerome, ID 83338
208-324-4700    

male pharmacist

James E Payton, R.PH.


Pharmacist
77 Horseshoe Cir, Jerome, ID 83338
208-539-1103    

male pharmacist

Dr. Jason Reading, PHARM-D


Pharmacist
133 W Avenue A, Jerome, ID 83338
208-324-3784     208-324-4599

female pharmacist

Lexa Marie Balling


Pharmacist
2680 S Lincoln Ave, Jerome, ID 83338
208-324-4700    

male pharmacist

Dr. Morgan B Parker, PHARM.D.


Pharmacist
1016 S Lincoln Ave, Jerome, ID 83338
208-324-2411    

male pharmacist

Dr. Peter A Gibbons, PHARMD


Pharmacist
2680 S Lincoln Ave, Jerome, ID 83338
208-324-4700     208-324-5052

male pharmacist

Dr. Troy M Jackman, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
709 N Lincoln Ave, Jerome, ID 83338
208-814-9716     208-814-9587


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.